Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tuberculosis Vaccine (U-VLP)
- Development stage
- Preclinical
- Lead developer
- Patronus Biotech
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
The Tuberculosis Vaccine (U-VLP) is a preclinical-stage vaccine candidate being developed by Patronus Biotech, a subsidiary of Luye Life Sciences. It utilizes the proprietary Universal Virus-Like Particle (U-VLP) platform to present *Mycobacterium tuberculosis* antigens on virus-like particles. This design is intended to induce both cell-mediated and humoral immune responses to provide protection against tuberculosis. The U-VLP platform aims to overcome limitations of traditional VLP approaches, such as production capacity and stability, and the vaccine is currently advancing toward Investigational New Drug (IND) applications.
- Other names
- U-VLP TB vaccinePatronus Biotech TB vaccine
Beyond the preview
Go deeper on Tuberculosis Vaccine (U-VLP).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tuberculosis Vaccine (U-VLP).